Advanced Flower Capital (AFCG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Board unanimously approved conversion from a REIT to a BDC, aiming for greater investment flexibility and alignment with long-term strategy.
Conversion will involve revoking REIT status and electing BDC regulation under the 1940 Act, with intent to qualify as a RIC for tax purposes.
Expanded investment mandate will allow broader portfolio diversification, including non-real estate-backed assets and middle-market companies.
Conversion expected to occur in the first quarter of 2026, pending shareholder approval.
Board believes benefits of enhanced flexibility and value creation outweigh associated risks.
Voting matters and shareholder proposals
Shareholders are asked to approve: (1) a new 1940 Act-compliant investment advisory agreement with AFC Management, LLC, and (2) application of reduced asset coverage requirements (from 200% to 150%) to permit increased leverage.
Board recommends voting FOR both proposals; approval of Proposal 1 is required for the conversion to proceed.
Special Meeting will be held virtually; only shareholders of record as of the record date may vote.
If proposals are not approved, the Board will consider alternatives, but conversion cannot proceed without Proposal 1.
Board of directors and corporate governance
Board and independent directors evaluated the new advisory agreement, considering service quality, fees, profitability, economies of scale, and ancillary benefits.
Board concluded the proposed fees are fair and not unreasonable, and unanimously approved the agreement for a two-year term.
Key executives include Leonard Tannenbaum (Chairman), Robyn Tannenbaum (President/CIO), and Daniel Neville (CEO).
Latest events from Advanced Flower Capital
- Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCG
Q2 202510 Mar 2026 - BDC conversion expanded investment scope; $31.3M interest income, $0.05 dividend declared.AFCG
Q4 20254 Mar 2026 - Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCG
Q2 20242 Feb 2026 - Q3 2024 earnings met targets, with strong originations and higher risk post-CRE spin-off.AFCG
Q3 202414 Jan 2026 - Exceeded origination targets, delivered strong yields, and maintained a robust pipeline.AFCG
Q4 202424 Dec 2025 - REIT lender to cannabis sector files $1B shelf registration for flexible equity and debt offerings.AFCG
Registration Filing16 Dec 2025 - Shareholders will vote on director election and auditor ratification, with Board support.AFCG
Proxy Filing2 Dec 2025 - Shareholders to vote on REIT-to-BDC conversion, new advisory agreement, and leverage increase.AFCG
Proxy Filing2 Dec 2025 - Vote on director election and auditor ratification at the May 2025 virtual annual meeting.AFCG
Proxy Filing2 Dec 2025